
Avita Medical, Inc.: shareholders and insiders
Price
$15.77
November 17, 2026Market cap $483M
What Ploutos Investor adds for Avita Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 9 fiscal years, from FY2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Jun 12, 2026, from their own Form 4 filings.
Insider trades start on July 21, 2020
Until lately Avita Medical was a foreign company listed in the US. Officers of foreign companies do not report their purchases and sales, so there are none before. They are not missing on our side: they were never filed.
- Until 2019Foreign company (annual report on 20-F)
- August 2020Becomes a US filer (annual report on 10-K)
- July 21, 2020The first insider trade report (Form 4)
Bought on the market
$226.6K
2 people
Sold on the market
–
nobody
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $234.6K by 2 people·no sales
- 2025: no buys, no sales
- 2026: bought $234.6K by 2 people, no sales
- Jun 12, 2026David D O'TooleCFOKind
- Jun 9, 2026Joseph Fralin WoodyDirectorKind
- Jun 9, 2026Joseph Fralin WoodyDirectorKind
- Jun 9, 2026Joseph Fralin WoodyDirectorKind
- Jun 3, 2026Joseph Fralin WoodyDirectorKind
- Jun 3, 2026Joseph Fralin WoodyDirectorKind
- Jun 2, 2026Joseph Fralin WoodyDirectorKind
- Jun 2, 2026Joseph Fralin WoodyDirectorKind
- Jun 1, 2026Joseph Fralin WoodyDirectorKind
- Jun 1, 2026Joseph Fralin WoodyDirectorKind
- May 29, 2026David D O'TooleCFOKind
- May 29, 2026Cary Guy VancePresident and CEOKind
- Jan 20, 2026Robert McNamaraDirectorKind
- Jan 20, 2026Joseph Fralin WoodyDirectorKind
- Jan 20, 2026Michael E TarnoffDirectorKind
- Jan 20, 2026Jeremy Curnock CookDirectorKind
- Jan 20, 2026Suzanne CroweDirectorKind
- Jan 20, 2026Jan Stern ReedDirectorKind
- Jan 5, 2026Joseph Fralin WoodyDirectorKind
- May 20, 2026David D O'TooleCFOKind
- May 19, 2026David D O'TooleCFOKind
- Mar 11, 2026David D O'TooleCFOKind
- Feb 19, 2026David D O'TooleCFOKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | David D O'TooleCFO | 2,000 | $3.97 | $7.9K | Form 4 | |
| Jun 9, 2026 | Joseph Fralin WoodyDirector | 5,200 | $4.00 | $20.8K | Form 4 | |
| Jun 9, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.20 | $21.0K | Form 4 | |
| Jun 9, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.18 | $20.9K | Form 4 | |
| Jun 3, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.10 | $20.5K | Form 4 | |
| Jun 3, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.09 | $20.4K | Form 4 | |
| Jun 2, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.18 | $20.9K | Form 4 | |
| Jun 2, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.21 | $21.0K | Form 4 | |
| Jun 1, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.34 | $21.7K | Form 4 | |
| Jun 1, 2026 | Joseph Fralin WoodyDirector | 5,000 | $4.26 | $21.3K | Form 4 | |
| May 29, 2026 | David D O'TooleCFO | 5,000 | $3.05 | $15.3K | Form 4 | |
| May 29, 2026 | Cary Guy VancePresident and CEO | 5,000 | $3.05 | $15.3K | Form 4 | |
| Jan 20, 2026 | Robert McNamaraDirector | 22.2K | – | – | Form 4 | |
| Jan 20, 2026 | Joseph Fralin WoodyDirector | 22.2K | – | – | Form 4 | |
| Jan 20, 2026 | Michael E TarnoffDirector | 22.2K | – | – | Form 4 | |
| Jan 20, 2026 | Jeremy Curnock CookDirector | 22.2K | – | – | Form 4 | |
| Jan 20, 2026 | Suzanne CroweDirector | 22.2K | – | – | Form 4 | |
| Jan 20, 2026 | Jan Stern ReedDirector | 22.2K | – | – | Form 4 | |
| Jan 5, 2026 | Joseph Fralin WoodyDirector | 40.5K | – | – | Form 4 | |
| May 20, 2026 | David D O'TooleCFO | 2,000 | $4.26 | $8.5K | Form 4 | |
| May 19, 2026 | David D O'TooleCFO | 2,000 | $4.24 | $8.5K | Form 4 | |
| Mar 11, 2026 | David D O'TooleCFO | 1,800 | $4.78 | $8.6K | Form 4 | |
| Feb 19, 2026 | David D O'TooleCFO | 3,000 | $4.15 | $12.5K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 1, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by RCEL's officers and directors from 2020 up to November 17, 2025, 6 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 1 more, back to 2020
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
Nobody reports more than 5% today: those who filed have since fallen to 5% or less.
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter-17%
- Millennium Mgmt (Englander)In the quarter
- Renaissance TechnologiesIn the quarter
- AQR CapitalIn the quarter+240%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 21.2K | -17% | $100.0K | 0.00% |
| Millennium Mgmt (Englander) | 15.4K | $100.0K | 0.00% | |
| Renaissance Technologies | 19.1K | $200.0K | 0.00% | |
| AQR Capital | 321.0K | +240% | $1.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 9.26% of its shares outstanding were held short, -1.8% since the report before.
- Shares held short
- 2.84M
- 9.26%
- Since the report before2.89M on Sep 30, 2026
- -1.8%
- 7.6
- 371.7K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 82%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 583.3K
- Nov 15, 2023: Shares held short 623.6K
- Nov 30, 2023: Shares held short 593.0K
- Dec 15, 2023: Shares held short 510.0K
- Dec 29, 2023: Shares held short 585.9K
- Jan 12, 2024: Shares held short 544.6K
- Jan 31, 2024: Shares held short 475.9K
- Feb 15, 2024: Shares held short 501.9K
- Feb 29, 2024: Shares held short 578.3K
- Mar 15, 2024: Shares held short 590.7K
- Mar 28, 2024: Shares held short 726.2K
- Apr 15, 2024: Shares held short 1.18M
- Apr 30, 2024: Shares held short 1.59M
- May 15, 2024: Shares held short 1.66M
- May 31, 2024: Shares held short 1.88M
- Jun 14, 2024: Shares held short 2.03M
- Jun 28, 2024: Shares held short 1.60M
- Jul 15, 2024: Shares held short 1.96M
- Jul 31, 2024: Shares held short 1.86M
- Aug 15, 2024: Shares held short 1.62M
- Aug 30, 2024: Shares held short 1.46M
- Sep 13, 2024: Shares held short 1.55M
- Sep 30, 2024: Shares held short 1.48M
- Oct 15, 2024: Shares held short 1.34M
- Oct 31, 2024: Shares held short 1.19M
- Nov 15, 2024: Shares held short 1.02M
- Nov 29, 2024: Shares held short 1.17M
- Dec 13, 2024: Shares held short 1.16M
- Dec 31, 2024: Shares held short 1.46M
- Jan 15, 2025: Shares held short 1.81M
- Jan 31, 2025: Shares held short 1.81M
- Feb 14, 2025: Shares held short 1.94M
- Feb 28, 2025: Shares held short 1.73M
- Mar 14, 2025: Shares held short 2.35M
- Mar 31, 2025: Shares held short 2.45M
- Apr 15, 2025: Shares held short 2.79M
- Apr 30, 2025: Shares held short 2.97M
- May 15, 2025: Shares held short 3.68M
- May 30, 2025: Shares held short 3.96M
- Jun 13, 2025: Shares held short 4.49M
- Jun 30, 2025: Shares held short 5.48M
- Jul 15, 2025: Shares held short 5.71M
- Jul 31, 2025: Shares held short 5.82M
- Aug 15, 2025: Shares held short 5.38M
- Aug 29, 2025: Shares held short 4.60M
- Sep 15, 2025: Shares held short 4.53M
- Sep 30, 2025: Shares held short 3.31M
- Oct 15, 2025: Shares held short 3.16M
- Oct 31, 2025: Shares held short 2.91M
- Nov 14, 2025: Shares held short 3.02M
- Nov 28, 2025: Shares held short 3.01M
- Dec 15, 2025: Shares held short 3.03M
- Dec 31, 2025: Shares held short 3.11M
- Jan 15, 2026: Shares held short 3.56M
- Jan 30, 2026: Shares held short 3.77M
- Feb 13, 2026: Shares held short 3.75M
- Feb 27, 2026: Shares held short 3.82M
- Mar 13, 2026: Shares held short 3.70M
- Mar 31, 2026: Shares held short 3.82M
- Apr 15, 2026: Shares held short 3.56M
- Apr 30, 2026: Shares held short 3.42M
- May 15, 2026: Shares held short 3.55M
- May 29, 2026: Shares held short 3.30M
- Jun 15, 2026: Shares held short 3.22M
- Jun 30, 2026: Shares held short 2.53M
- Jul 15, 2026: Shares held short 2.62M
- Jul 31, 2026: Shares held short 2.61M
- Aug 14, 2026: Shares held short 2.75M
- Aug 31, 2026: Shares held short 2.94M
- Sep 15, 2026: Shares held short 2.89M
- Sep 30, 2026: Shares held short 2.89M
- Oct 15, 2026: Shares held short 2.84M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading51.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 51.3% of the shares in the reported trades were short sales, against 63.2% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 51.3%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 63.2%
- Change
- -11.9 pts
- Short sales a dayon average, of 299.2K shares
- 153.5K
- More than atof 3,666 US-listed companies, same days
- 54%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 59.7%
- Oct 12, 2026: Short sales 57.4%
- Oct 13, 2026: Short sales 63.9%
- Oct 14, 2026: Short sales 54%
- Oct 15, 2026: Short sales 58%
- Oct 16, 2026: Short sales 55.1%
- Oct 19, 2026: Short sales 73.8%
- Oct 20, 2026: Short sales 66.1%
- Oct 21, 2026: Short sales 66.4%
- Oct 22, 2026: Short sales 64.9%
- Oct 23, 2026: Short sales 59.2%
- Oct 26, 2026: Short sales 77.2%
- Oct 27, 2026: Short sales 74.1%
- Oct 28, 2026: Short sales 56.3%
- Oct 29, 2026: Short sales 45.4%
- Oct 30, 2026: Short sales 51.7%
- Nov 2, 2026: Short sales 45.2%
- Nov 3, 2026: Short sales 60.3%
- Nov 4, 2026: Short sales 50.2%
- Nov 5, 2026: Short sales 65%
- Nov 6, 2026: Short sales 54%
- Nov 9, 2026: Short sales 45.4%
- Nov 10, 2026: Short sales 60.6%
- Nov 11, 2026: Short sales 51%
- Nov 12, 2026: Short sales 52%
- Nov 13, 2026: Short sales 30.1%
- Nov 16, 2026: Short sales 40.4%
- Nov 17, 2026: Short sales 70.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- David D O'TooleCFODirectly152.9K
- Robert McNamaraDirectorDirectly109.0K
- Joseph Fralin WoodyDirectorDirectly108.0K
- Jan Stern ReedDirectorDirectly73.2K
- Suzanne CroweDirectorDirectly69.1K
- Jeremy Curnock CookDirectorDirectly62.1K
- Michael E TarnoffDirectorDirectly48.5K
- Cary Guy VancePresident and CEODirectly40.8K
- James CorbettCEODirectly11.6K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| David D O'TooleCFO | 152.9K | – | Jun 12, 2026 | Form 4 |
| Robert McNamaraDirector | 109.0K | – | Jan 20, 2026 | Form 4 |
| Joseph Fralin WoodyDirector | 108.0K | – | Jun 9, 2026 | Form 4 |
| Jan Stern ReedDirector | 73.2K | – | Jan 20, 2026 | Form 4 |
| Suzanne CroweDirector | 69.1K | – | Jan 20, 2026 | Form 4 |
| Jeremy Curnock CookDirector | 62.1K | – | Jan 20, 2026 | Form 4 |
| Michael E TarnoffDirector | 48.5K | – | Jan 20, 2026 | Form 4 |
| Cary Guy VancePresident and CEO | 40.8K | – | May 29, 2026 | Form 4 |
| James CorbettCEO | 11.6K | – | Dec 26, 2023 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.03%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- ITOTiShares Core S&P Total U.S. Stock Market ETFWeight in the fund0.00%
4 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 76
- Q4 2025: Managers 67
- Q1 2026: Managers 80
- Q2 2026: Managers 73
Institutional investors by quarter
The fund managers holding RCEL, quarter by quarter, from Q3 2013 to Q2 2025, 31 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 73 managers held 4.93M shares, worth $20M. During the quarter 20 opened a position, 26 closed one, 25 added and 20 trimmed.
The largest holders, Q2 2026
- Vanguard Capital ManagementIn the quarter
- BlackRockIn the quarter-50%
- Geode Capital ManagementIn the quarter-37%
- Marshall WaceIn the quarter+544%
- AQR CapitalIn the quarter+240%
- Morgan StanleyIn the quarter+27%
- Vanguard Fiduciary TrustIn the quarter-5.7%
- NewEdge AdvisorsIn the quarter+71%
- Macquarie GroupIn the quarter×12.1
- State StreetIn the quarter-70%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Vanguard Capital Management | 1.33M | $5.5M | |
| BlackRock | 565.0K | -50% | $2.3M |
| Geode Capital Management | 339.8K | -37% | $1.4M |
| Marshall Wace | 338.4K | +544% | $1.4M |
| AQR Capital | 321.0K | +240% | $1.3M |
| Morgan Stanley | 200.5K | +27% | $827.9K |
| Vanguard Fiduciary Trust | 182.4K | -5.7% | $753.3K |
| NewEdge Advisors | 148.9K | +71% | $615.1K |
| Macquarie Group | 144.2K | ×12.1 | $595.4K |
| State Street | 129.0K | -70% | $532.7K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Avita Medical's filings show?
Who buys and sells is one part of Avita Medical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have RCEL's insiders bought or sold?
From Jun 1, 2026 to Jun 12, 2026 Avita Medical's insiders bought $188.6K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.
Which well-known managers hold RCEL?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $1.3M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.